Shares of Divi’s Laboratories hit a new high of Rs 1,617, up 5 per cent on BSE in the intra-day trade on Monday after the company posted a robust growth of 69 per cent in net profit at Rs 379 crore in December quarter (Q3FY19). The pharmaceutical company had posted a profit of Rs 225 crore in a year-ago quarter.
Operational revenue during the quarter grew 29 per cent at Rs 1,343 crore, against Rs 1,038 crore in the corresponding quarter of previous fiscal.
Analysts, on an average, had expected a profit of Rs 346 crore on revenue of Rs
Operational revenue during the quarter grew 29 per cent at Rs 1,343 crore, against Rs 1,038 crore in the corresponding quarter of previous fiscal.
Analysts, on an average, had expected a profit of Rs 346 crore on revenue of Rs